Open in app

Teplizumab, the first medication to prevent the onset of diabetes, has received FDA approval.

img-1
Total Views:
499
img-1
Total Likes:
42
img-1
Published By:
Peeyush Ghalot
img-1
Published On:
29-11-2022
(Photo Courtesy: - CNN)

The first medication that might postpone the onset of Type 1 diabetes was approved by the U.S. Food and Drug Administration (T1D). Teplizumab (Tzield), a game-changing drug, tackles the immunological problems that cause the disease rather than just its symptoms. According to a news release from the FDA's Center for Drug Evaluation and Research, the approval of a first-in-class medicine "adds an essential new treatment option for certain at-risk patients." Dr. John Sharretts is the division's director for diabetes, lipid diseases, and obesity. Patients may experience months or years without the effects of the condition thanks to the drug's capacity to delay the clinical diagnosis of Type 1 diabetes. The daily lives of those at risk for diabetes, their families, and the whole health system will be significantly impacted by a delay in the onset of Type 1 diabetes, according to Aaron Kowalski, CEO of the organisation JDRF (previously the Juvenile Diabetes Research Foundation), in a statement. High risk individuals are those who have two or more T1D-related autoantibodies and whose blood sugar levels are beginning to be abnormal.

Reference: - https://www.upi.com/Health_News/2022/11/18/FDA-drug-Type-1-diabetes/2031668785736/